124 related articles for article (PubMed ID: 31183237)
1. A Case of Suspected Adverse Reactions to Sirolimus in the Treatment of Generalized Lymphatic Anomaly.
Fujii T; Shimono R; Tanaka A; Katami H
Case Rep Pediatr; 2019; 2019():3101357. PubMed ID: 31183237
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).
Ozeki M; Asada R; Saito AM; Hashimoto H; Fujimura T; Kuroda T; Ueno S; Watanabe S; Nosaka S; Miyasaka M; Umezawa A; Matsuoka K; Maekawa T; Yamada Y; Fujino A; Hirakawa S; Furukawa T; Tajiri T; Kinoshita Y; Souzaki R; Fukao T
Regen Ther; 2019 Jun; 10():84-91. PubMed ID: 30705924
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial.
Ozeki M; Endo S; Yasue S; Nozawa A; Asada R; Saito AM; Hashimoto H; Fujimura T; Yamada Y; Kuroda T; Ueno S; Watanabe S; Nosaka S; Miyasaka M; Umezawa A; Matsuoka K; Maekawa T; Hirakawa S; Furukawa T; Fumino S; Tajiri T; Takemoto J; Souzaki R; Kinoshita Y; Fujino A
Front Med (Lausanne); 2024; 11():1335469. PubMed ID: 38390569
[TBL] [Abstract][Full Text] [Related]
5. Kaposiform Lymphangiomatosis in a Male Adolescent: A Clinical Challenge and the Role of Genetics.
Pereira-Nunes J; Madureira M; Dinis A; Barroca H; Lima J; do Bom-Sucesso M
J Investig Med High Impact Case Rep; 2023; 11():23247096231166678. PubMed ID: 37148180
[TBL] [Abstract][Full Text] [Related]
6. Chylothorax and constrictive pericarditis in a woman due to generalized lymphatic anomaly: a case report.
Du H; Xiong M; Liao H; Luo Y; Shi H; Xie C
J Cardiothorac Surg; 2018 Jun; 13(1):59. PubMed ID: 29871646
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.
Ozeki M; Fujino A; Matsuoka K; Nosaka S; Kuroda T; Fukao T
Pediatr Blood Cancer; 2016 May; 63(5):832-8. PubMed ID: 26806875
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus in the treatment of kaposiform lymphangiomatosis.
Zhou J; Yang K; Chen S; Ji Y
Orphanet J Rare Dis; 2021 Jun; 16(1):260. PubMed ID: 34103076
[TBL] [Abstract][Full Text] [Related]
10. Generalized lymphatic anomaly successfully treated with long-term, low-dose sirolimus.
Dvorakova V; Rea D; O'Regan GM; Irvine AD
Pediatr Dermatol; 2018 Jul; 35(4):533-534. PubMed ID: 29582448
[TBL] [Abstract][Full Text] [Related]
11. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
[TBL] [Abstract][Full Text] [Related]
12. Generalized Lymphatic Anomaly and Gorham-Stout Disease: Overview and Recent Insights.
Ozeki M; Fukao T
Adv Wound Care (New Rochelle); 2019 Jun; 8(6):230-245. PubMed ID: 31236308
[No Abstract] [Full Text] [Related]
13. Somatic activating mutations in
Rodriguez-Laguna L; Agra N; Ibañez K; Oliva-Molina G; Gordo G; Khurana N; Hominick D; Beato M; Colmenero I; Herranz G; Torres Canizalez JM; Rodríguez Pena R; Vallespín E; Martín-Arenas R; Del Pozo Á; Villaverde C; Bustamante A; Ayuso C; Lapunzina P; Lopez-Gutierrez JC; Dellinger MT; Martinez-Glez V
J Exp Med; 2019 Feb; 216(2):407-418. PubMed ID: 30591517
[TBL] [Abstract][Full Text] [Related]
14. Generalized lymphatic anomaly involving the pleura and bone in an older male: A case report.
Yanagisawa A; Tamiya A; Takimoto T; Sumikawa H
Respir Med Case Rep; 2023; 46():101961. PubMed ID: 38187118
[TBL] [Abstract][Full Text] [Related]
15. Successful Sirolimus Treatment for Recurrent Pericardial Effusion in a Large Cervicomediastinal Provisionally Unclassified Vascular Anomaly: A Case Report.
Moreno-Alfonso JC; San Basilio Berenguer M; Sarmiento Caldas MDC; González Cayón J; de la Puente S; Triana P; López-Gutiérrez JC
European J Pediatr Surg Rep; 2023 Jan; 11(1):e20-e24. PubMed ID: 37206983
[TBL] [Abstract][Full Text] [Related]
16. Complex lymphatic anomalies.
Trenor CC; Chaudry G
Semin Pediatr Surg; 2014 Aug; 23(4):186-90. PubMed ID: 25241096
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietins as serum biomarkers for lymphatic anomalies.
Le Cras TD; Mobberley-Schuman PS; Broering M; Fei L; Trenor CC; Adams DM
Angiogenesis; 2017 Feb; 20(1):163-173. PubMed ID: 27990590
[TBL] [Abstract][Full Text] [Related]
18. Gorham-Stout Disease Successfully Treated With Sirolimus and Zoledronic Acid Therapy.
Cramer SL; Wei S; Merrow AC; Pressey JG
J Pediatr Hematol Oncol; 2016 Apr; 38(3):e129-32. PubMed ID: 26886375
[TBL] [Abstract][Full Text] [Related]
19. A case of diffuse pulmonary lymphangiomatosis with a venous anomaly presenting with acute respiratory failure and hemoptysis.
Nagano N; Izumi S; Katsuno T; Iikura M; Miyazaki H; Igari T; Okafuji T; Sekihara K; Nagasaka S; Hojo M
Respir Med Case Rep; 2020; 31():101243. PubMed ID: 33088708
[TBL] [Abstract][Full Text] [Related]
20. A Case of a Central Conducting Lymphatic Anomaly Responsive to Sirolimus.
McCormick A; Rosenberg S; Trier K; Balest A
Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26729539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
